“…This dose reduction technology has already been shown to reduce radiation dose in neuroradiology patients, 8,9 electrophysiology patients, 10 in digital subtraction angiography preclinical studies, 11 and for pediatric and congenital heart disease patients. 12 The work described here evaluates the degree of dose reduction from using this new technology installed in a dedicated cardiac catheterization laboratory (Allura Xper FD20/10, Philips Healthcare, Best, the Netherlands) for diagnostic CA and PCI procedures, compared to dose received by patients in a standard cardiac catheterization laboratory (Allura Xper FD20, Philips Healthcare, Best, the Netherlands) that does not have this technology available. To the best of our knowledge, this is the first evaluation of this technology for PCI (interventional) and CA (diagnostic) patients in an interventional cardiology setting in North America.…”